drugset / Trial / NCT02403895
AZD2014 and Weekly Paclitaxel in Squamous NSCLC
NaSingle-groupOpen-labelTreatment
Summary
Open--label, phase 2a, multi-centre, single-arm study to assess the efficacy and safety of AZD2014 and weekly paclitaxel in patients with squamous non-small cell lung cancer (NSCLC)
Timeline
- Start
- 2015-04-15
- Primary completion
- 2016-12-29
- Completion
- 2016-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 80 mg/m2 | — |
| Subject | Vistusertib | Small molecule | 50 mg | Oral |